Search

everythinglearnresearchcommunity

for

Search:↓

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Generalized glucocorticoid resistance causes hormone imbalances and varied symptoms due to gene mutations.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

High androgen levels cause skin issues in PCOS, affecting quality of life.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Understanding hair growth involves complex factors, and more research is needed to improve treatments for hair loss conditions.

Dexamethasone increases the activity of androgen receptors in human skin cells, which may link it to certain types of hair loss.

PCOS has many symptoms, with high androgen levels being the most common.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Minoxidil and Finasteride are effective for male baldness; more research is needed for hair aging treatments.

Age, smoking, and lower BMI increase facial wrinkles; men wrinkle more than women, except in old age; pale skin and certain hormonal factors can protect against wrinkles.

PCOS treatment should address both symptoms and metabolic risks, starting with lifestyle changes and possibly including medication.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Androgens promote beard growth but cause hair loss in androgenetic alopecia, with TGF-β1 as a potential treatment target.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

Hair loss patterns differ between males and females due to 5 master regulators and JAK-STAT signaling affects hair growth.

Understanding hair follicles through various models can help develop new treatments for hair disorders.

Energy healing treatment improved flutamide's solubility and stability, potentially enhancing its effectiveness for prostate cancer.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.